Search - tctmd.com

Displaying 1 - 20 of 40

Sort: Relevancy | Date

News Daily News

PREVENT-TAHA8: Post-MI Intracoronary Stem Cells May Lower HF Risk After STEMI

L.A. McKeown

November 04, 2025

News Daily News

CVD Risk Twofold Higher in Patients With Cancer: ASPREE

Michael O'Riordan

September 27, 2024

News Industry News

CellProthera announces positive Phase I/IIb data for ProtheraCytes® cell therapy in acute myocardial infarction

May 29, 2024

News Conference News AHA 2023

MINT Hints at Benefits of Liberal Transfusions in Acute MI With Anemia

L.A. McKeown

November 11, 2023

News Daily News

Acute MI Patients Without Standard CVD Risk Factors at Higher Risk of Death

Michael O'Riordan

July 07, 2023

News Opinion CV Team Dispatch

November 2022 News Roundup

L.A. McKeown

November 01, 2022

News Opinion Editor's Corner AHA 2021

AHA 2021 Tackles AF Triggers, Watchful Waiting in AS, Data Overload, and More

Shelley Wood

November 08, 2021

News Daily News

Microvascular Thrombi Common in Patients Dying of COVID-19

Michael O'Riordan

January 27, 2021

News Daily News

Takotsubo Rising During COVID-19? Stress, Viral Triggers Need Attention

Yael L. Maxwell

May 08, 2020

News Daily News

Cardiac Injury in COVID-19 Sharply Increases Risk of Death

Caitlin E. Cox

March 26, 2020

News Daily News

Counting CPCs May Beat Stress Tests for Stratifying CAD Risk

Yael L. Maxwell

December 11, 2019

News Conference News ACC 2018

SECURE-PCI Comes Up Short for Statin Preloading in ACS Patients

Michael O'Riordan

March 11, 2018

News Daily News

Less Acute MI, More HF: European Task Force Shifts Support for ‘Overhyped’ Cell Therapy Research

Yael L. Maxwell

February 22, 2017

News Conference News ESC 2016

Use of Antithrombotics Instead of Stents Appears Safe, Reduces Thrombus Burden in Subset of ACS Patients: EROSION

Michael O'Riordan

August 30, 2016

News Conference News ESC 2015

PRESERVATION I: Bioabsorbable Cardiac Matrix Does Not Benefit STEMI Patients

Yael L. Maxwell

September 02, 2015

News Industry News

Beike Biotechnology Publishes New Research Finding Adult Mesenchymal Stem Cells Safe and Effective in Acute Myocardial Infarction

July 22, 2015

News Daily News

Catheter-Delivered Gene Therapy Yields Positive Signal in Advanced Heart Failure

June 23, 2015

Presentation CATCH-UP 2015

Mesenchymal Lineage Adult Stem Cells In Cardiovascular Disease

Presenter: Silviu Itescu

April 24, 2015

News Daily News

Meta-analysis: Bone Marrow Mononuclear Cell Therapy Fails to Show Efficacy in Acute MI

Yael L. Maxwell

April 08, 2014

News Daily News

HORIZONS-AMI: Kidney Damage During Primary PCI Closely Tied to Prognosis

March 20, 2014

Advertisement

PREVENT-TAHA8: Post-MI Intracoronary Stem Cells May Lower HF Risk After STEMI

CVD Risk Twofold Higher in Patients With Cancer: ASPREE

CellProthera announces positive Phase I/IIb data for ProtheraCytes® cell therapy in acute myocardial infarction

MINT Hints at Benefits of Liberal Transfusions in Acute MI With Anemia

Acute MI Patients Without Standard CVD Risk Factors at Higher Risk of Death

November 2022 News Roundup

AHA 2021 Tackles AF Triggers, Watchful Waiting in AS, Data Overload, and More

Microvascular Thrombi Common in Patients Dying of COVID-19

Takotsubo Rising During COVID-19? Stress, Viral Triggers Need Attention

Cardiac Injury in COVID-19 Sharply Increases Risk of Death

Counting CPCs May Beat Stress Tests for Stratifying CAD Risk

SECURE-PCI Comes Up Short for Statin Preloading in ACS Patients

Less Acute MI, More HF: European Task Force Shifts Support for ‘Overhyped’ Cell Therapy Research

Use of Antithrombotics Instead of Stents Appears Safe, Reduces Thrombus Burden in Subset of ACS Patients: EROSION

PRESERVATION I: Bioabsorbable Cardiac Matrix Does Not Benefit STEMI Patients

Beike Biotechnology Publishes New Research Finding Adult Mesenchymal Stem Cells Safe and Effective in Acute Myocardial Infarction

Catheter-Delivered Gene Therapy Yields Positive Signal in Advanced Heart Failure

Mesenchymal Lineage Adult Stem Cells In Cardiovascular Disease

Meta-analysis: Bone Marrow Mononuclear Cell Therapy Fails to Show Efficacy in Acute MI

HORIZONS-AMI: Kidney Damage During Primary PCI Closely Tied to Prognosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content